Brief: Hemogenyx Pharma Announces Administration Of First-In-Human Treatment With HG-CT-1

Hemogenyx Pharmaceuticals

24/02/2025 07:16

Feb 24 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * HEMOGENYX PHARMA PLC  - FIRST-IN-HUMAN TREATMENT WITH
HG-CT-1
    * HEMOGENYX PHARMACEUTICALS : ANNOUNCE ADMINISTRATION OF
FIRST-IN-HUMAN TREATMENT WITH HG-CT-1 FOR RELAPSED OR REFRACTORY
ACUTE MYELOID LEUKEMIA

Source text:  ID:nRSX1775Ya 
Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;))